title: Adalimumab arrests bone loss in the spine and hip of active rheumatoid arthritis patients with osteopenia.
authors.affiliation: Department of Rheumatology, General Hospital of Ningxia Medical University, Yinchuan, Ningxia; and Department of Rheumatology, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
authors.forename: Haibo
authors.initials: H
authors.lastname: Li
authors.affiliation: Department of Rheumatology, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
authors.forename: Rongqing
authors.initials: R
authors.lastname: Liu
authors.affiliation: Department of Rheumatology, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
authors.forename: Shuhong
authors.initials: S
authors.lastname: Chi
authors.affiliation: Department of Chinese Traditional Orthopaedics, the General Hospital of Ningxia Medical University, Yinchuan, China.
authors.forename: Zongzhi
authors.initials: Z
authors.lastname: Lu
authors.affiliation: Department of Rheumatology, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
authors.forename: Lijuan
authors.initials: L
authors.lastname: Yang
mesh_terms: D015502:Absorptiometry, Photon; D000068879:Adalimumab; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000097:blood / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D015415:Biomarkers / Q000097:blood; D015519:Bone Density / Q000187:drug effects; D001851:Bone Diseases, Metabolic / Q000097:blood / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control*; D016022:Case-Control Studies; D024042:Collagen Type I / Q000097:blood; D006621:Hip Joint / Q000000981:diagnostic imaging / Q000187:drug effects* / Q000378:metabolism; D006801:Humans; D008159:Lumbar Vertebrae / Q000000981:diagnostic imaging / Q000187:drug effects* / Q000378:metabolism; D010455:Peptides / Q000097:blood; D012720:Severity of Illness Index; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D015415:Biomarkers; D024042:Collagen Type I; D010455:Peptides; C052929:collagen type I trimeric cross-linked peptide; D000068879:Adalimumab